Interventional Nephrology

ASN President's Column: Strategic Goals for 2019

I am honored to be ASN President in 2019 and excited by the possibilities for this year. ASN developed and launched a 5-year strategic plan in 2016. Significant progress has been made on all strategic goals, and these remain as the main issues ASN will need to address over the course of the next year. In 2019, I’d like to see ASN focus on accomplishing three broad goals that will continue the society’s momentum and help accomplish the strategic plan by the end of 2020.

Nominations for ASN Midcareer Awards are Open

Nominations for ASN’s midcareer awards are open. These awards identify those who exemplify the very best in our field. Recognize your peers for their work in the fight against kidney disease.

To nominate a candidate, submit one letter of nomination and the nominee’s curriculum vitae (CV). Please note that ASN can only accept one nomination letter per candidate; however, the letter may have multiple signatories.

The deadline for all ASN midcareer awards nominations is through Friday, March 22, 2019.

The Kidney Health Initiative (KHI) Year in Review

“What I have learned more than anything else, is that if you get talented and committed people from different backgrounds together, then wonderful and impactful things just seem to happen.” Prabir Roy-Chaudhury, MD, PhD, FASN, ASN Co-Chair for the Kidney Health Initiative

Marcello Tonelli, MD, SM, MSc speaks about the complexities of treating nephrology patients in recent study

tonelli.jpgA recent study was published online in the Journal of the American Medical Association (JAMA) entitled “Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System” on November 30, 2018.

Please access the abstract and full report on the JAMA website.

ASN Releases 2018 Nephrology Fellow Survey Report

A new analysis finds leading indicators point to an improving job market and rising salaries for nephrologists entering practice. ASN released the analysis of the society’s annual survey of nephrology fellows in training—Report on the Survey of 2018 Nephrology Fellows—authored by George Washington University researchers.

KHI Patient Council Members Will Be Presenters in Kidney Week 2018 Special Session

The Kidney Week 2018 Special Session “Measuring What is Important to Patients: A Patient-Centered Approach to Innovation,” featuring members of the Kidney Health Initiative Patient and Family Partnership Council (KHI PFPC), will examine some of the ways we and our colleagues are delivering value as partners in kidney disease research.

Redesign of Online ASN Journals Ready to Improve User Experience

The Journal of the American Society of Nephrology (JASN) and the Clinical Journal of American Society of Nephrology (CJASN) online platforms have been relaunched with increased functionality and a new interface providing readers with an on-the-go experience designed for all devices.

The relaunched sites with their modern design, contain numerous new features and functions making the reader experience easier and more efficient – thereby helping ensure that readers and authors can find what they’re looking for when they need it.

Communities Weekly Rewind: Hope and Innovation in Nephrology

Months of efforts by ASN staff culminated on April 26, 2018, when ASN signed a Memorandum of Understanding with the Department of Health and Human Services to establish the Kidney Innovation Accelerator, KidneyX.

Benjamin Freedman, PhD speaks about CRISPR and the future of treating polycystic kidney disease in recent study: "Organoid cystogenesis reveals a critical role of microenvironment in human PKD"

A recent study was published online in Nature Materials entitled “Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease” on October 2, 2017.

Please access the abstract and full report on the Nature website.

The Fifth Annual Kidney Health Initiative (KHI) Stakeholders Meeting and the Eighth Project Submission Cycle

The Kidney Health Initiative (KHI), a public-private partnership between the American Society of Nephrology (ASN) and the U.S. Food and Drug Administration (FDA), continues to advance its mission of facilitating innovation and patient safety in kidney disease through its collaborative partnership with the kidney community.

Pages